Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Bone Marrow Transplantation

• Publication date

  1994-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 7920309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of cytokines in graft-versus-host reactions and disease.

  1992cited by this paper
• THE RELATIONSHIP OF SERUM IL‐6 LEVELS TO ACUTE GRAFT‐VERSUS‐HOST DISEASE AND HEPATORENAL DISEASE AFTER HUMAN BONE MARROW TRANSPLANTATION

  1992cited by this paper
• Serum levels and receptor expression of tumor necrosis factor-alpha following human allogeneic and autologous bone marrow transplantation.

  1992cited by this paper
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

  1992cited by this paper
• Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages.

  1990cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• Cytokines: coordinators of immune and inflammatory responses.

  1990cited by this paper
• Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans.

  1990cited by this paper
• Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

  1990cited by this paper
• Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production.

  1990cited by this paper
• Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group

  1989cited by this paper
• Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.

  1989cited by this paper
• Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.

  1989cited by this paper
• Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha.

  1989cited by this paper
• Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression.

  1988cited by this paper
• In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.

  1988cited by this paper
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

  1987cited by this paper
• Interferon alpha/beta synthesis during acute graft-versus-host disease.

  1987cited by this paper
• Lymphokines.

  1987cited by this paper
• Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.

  1987cited by this paper
• T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2.

  1986cited by this paper
• EXPRESSION OF HLA ANTIGENS ON RENAL TUBULAR CELLS IN CULTURE: I. EVIDENCE THAT MIXED LYMPHOCYTE CULTURE SUPERNATANTS AND GAMMA INTERFERON INCREASE BOTH CLASS I AND CLASS II HLA ANTIGENS

  1986cited by this paper
• Acute and chronic graft-versus-host disease in man.

  1986cited by this paper
• Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.

  1982cited by this paper
• Natural killer activity by spleen, lymph node, and thymus cells during the graft-versus-host reaction.

  1982cited by this paper
• SUBSETS OF T CELLS IN THE RAT MEDIATING LETHAL GRAFT‐VERSUS-HOST DISEASE

  1981cited by this paper
• Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

  1978cited by this paper
• Bone-marrow transplantation (second of two parts).

  1975cited by this paper

• Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.

  2025cites this paper
• DecodingAcute GVHD: The role of serum biomarkers and imaging in diagnosis and management.

  2025cites this paper
• Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury

  2025cites this paper
• Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

  2024cites this paper
• IFN-γ induces acute graft-versus-host disease by promoting HMGB1-mediated nuclear-to-cytoplasm translocation and autophagic degradation of p53

  2024cites this paper
• The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells

  2024cites this paper
• Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies

  2024cites this paper
• A pilot study of donor-engrafted clonal hematopoiesis evolution and clinical outcomes in allogeneic hematopoietic cell transplant recipients using a national registry.

  2023cites this paper
• Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

  2023cites this paper
• The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations

  2021cites this paper
• Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children

  2021cites this paper
• Immunopathology and Biology Based Treatment of Steroid Refractory Graft-versus-Host Disease.

  2020cites this paper
• Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms

  2020cites this paper
• Interferon-γ-stimulated apoptotic keratinocytes promote sclerodermatous changes in chronic graft-versus-host disease.

  2020cites this paper
• Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

  2020cites this paper
• Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren’s syndrome

  2020cites this paper
• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Hematopoietic Cell Transplantation, Version 2.2020

  2020cites this paper
• Emerging Topical and Systemic JAK Inhibitors in Dermatology

  2019cites this paper
• Resolution of acute intestinal graft-versus-host disease

  2019cites this paper
• Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide

  2019cites this paper
• Bone Complications in Allogenic Hematopoietic Stem Cell Transplantation

  2019cites this paper
• Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

  2018cites this paper
• Killer Immunoglobulin like Receptor-Human Leukocyte Antigen Ligand Match/Mismatch in Graft Loss Post Transplant Cyclophosphamide Based Hap loidentical Transplant

  2018cites this paper
• Killer Immunoglobulin like Receptor and Hematopoetic Stem Cell Transplantation: A Brief Review

  2018cites this paper
• Characterization of monocyte subtypes regarding their phenotype and development in the context of graft-versus-host disease.

  2018cites this paper
• Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target

  2017cites this paper
• Profiles of pro‐inflammatory cytokines in allogenic stem cell transplantation with post‐transplant cyclophosphamide

  2017cites this paper
• Instructions for use Title Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation : a case report

  2017cites this paper
• Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?

  2016cites this paper
• The effect of low-dose methotrexate on autologous fat graft survival.

  2016cites this paper
• Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation

  2015cites this paper
• Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients

  2015cites this paper
• Leukoderma and chronic inflammatory demyelinating polyradiculoneuropathy in an adolescent with graft-versus-host disease

  2015cites this paper
• Identification and validation of biomarkers associated with acute and chronic graft versus host disease

  2015cites this paper
• Treatment of Severe Chronic Graft-Versus-Host Disease with Decidual Stromal Cells and Tracing with 111Indium Radiolabeling

  2015cites this paper
• Association between Interlukin-6 (IL-6), Interlukin-10 (IL-10) and depression in patients undergoing Hematopoietic stem cell transplantation

  2015cites this paper
• Safety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation

  2014cites this paper
• Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts.

  2014cites this paper
• Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment.

  2014cites this paper
• biomarkers of chronic graft-versus-host disease MICA-129 genotype, soluble MICA, and anti-MICA antibodies as

  2013cites this paper
• Microarray gene expression in immunological conditions

  2013cites this paper
• Biomarkers for acute GVHD: can we predict the unpredictable?

  2013cites this paper
• The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease

  2013cites this paper
• Clinical applications for biomarkers of acute and chronic graft-versus-host disease.

  2012cites this paper
• Complete remission following chemotherapy with low-dose cytosine arabinoside and macrophage colony-stimulating factor/granulocyte colony-stimulating factor in a patient with relapsed acute myeloid leukemia after stem cell transplantation.

  2012cites this paper
• Kinetics of T Helper Subsets and Associated Cytokines Correlate Well with the Clinical Activity of Graft-Versus-Host Disease

  2012cites this paper
• Factor ROR Disease in the Absence of the Transcription Attenuation of Acute Graft-versus-Host

  2012cites this paper
• Early-Onset Chronic Inflammatory Disease Associated with Maternal Microchimerism

  2012cites this paper
• Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• Attenuation of Acute GvHD in the Absence of the Transcription Factor ROR γ t

  2012cites this paper
• Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?

  2012cites this paper
• A meta-analysis of the effects of interleukin-6 -174 G>C genetic polymorphism on acute graft-versus-host disease susceptibility.

  2012cites this paper
• Microsatellite scanning of the immunogenome for associations with graft-versus-host disease following haematopoietic stem cell transplantation

  2012cites this paper
• transplantation graft-versus-host disease in HLA-matched sibling bone marrow and interleukin-6 gene polymorphisms associate with γ Interferon-

  2012cites this paper
• Attenuation of Acute Graft-versus-Host Disease in the Absence of the Transcription Factor RORγt

  2012cites this paper
• Clinical Applications for Biomarkers of Acute and Chronic Graft vs. Host Disease

  2012cites this paper
• Potential biomarkers for early detection of acute graft‐versus‐host disease

  2012influential citation
• TH17 Cells, Proteins Associated with TH17 Polarization, and Their Role in Graft vs. Host Disease

  2011cites this paper
• Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease

  2011cites this paper
• Implications of TNF-α in the pathogenesis and management of GVHD

  2011cites this paper
• Relation of Soluble Endothelial Protein C Receptor and Cytokines After Allogeneic Hematopoietic Stem Cell Transplantation

  2011cites this paper
• Tocilizumab for the treatment of steroid refractory graft-versus-host disease.

  2011cites this paper
• Eosinophilia predicts better overall survival after acute graft-versus-host-disease

  2010cites this paper
• Regulation of acute graft-versus-host disease by microRNA-155.

  2010cites this paper
• In vitro Studies of Titanium Alloy Discs Fabricated with Electron Beam Melting for Improving Transdermal Osseointegrated Implant Surfaces.

  2010cites this paper
• Relação entre polimorfismos genéticos e níveis de citocinas com a doença do enxerto contra o hospedeiro aguda no transplante alogênico de células-tronco hematopoiéticas

  2010influential citation
• CD20, AIF-1, and TGF-β in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies

  2010cites this paper
• Genetic polymorphisms in the cytokine and chemokine system: their possible importance in allogeneic stem cell transplantation.

  2010cites this paper
• In vitro biocompatibility of titanium alloy discs made using direct metal fabrication.

  2010cites this paper
• Chronic graft-versus-host disease (GVHD) in children.

  2010cites this paper
• Plasma biomarkers in GVHD: a new era?

  2009cites this paper
• Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells

  2009cites this paper
• Plasma biomarkers in graft-versus-host disease: a new era?

  2009cites this paper
• Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.

  2009cites this paper
• MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease.

  2009cites this paper
• Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study

  2009cites this paper
• Graft-versus-Leukemia Effect of Nonmyeloablative Stem Cell Transplantation

  2009cites this paper
• Design and Validation of Three-Dimensional Scaffolds for Bone Tissue Engineering Applications Using Human Adipose-Derived Adult Stem Cells

  2009cites this paper
• A biomarker panel for acute graft-versus-host disease.

  2009cites this paper
• Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.

  2009cites this paper
• Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients.

  2008cites this paper
• Vitiligo after Hematopoietic Cell Transplantation: Six Cases and Review of the Literature

  2008cites this paper
• Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

  2008cites this paper
• Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children

  2008cites this paper
• Papel das citocinas na imunopatognese da doena do enxerto contra o hospedeiro

  2008cites this paper
• Role Of Cytokines In The Immunopathogenesis Of Graft-versus-host Disease [papel Das Citocinas Na Imunopatogênese Da Doença Do Enxerto Contra O Hospedeiro]

  2008cites this paper
• Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant

  2007cites this paper
• CXCL 10-CXCR 3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation

  2007cites this paper
• Severe graft versus host disease in a patient with globoid cell leukodystrophy following umbilical cord blood transplantation: resemblance to the twitcher mouse model.

  2007cites this paper
• Thyroid Function Changes and Cytokine Alterations following Major Surgery

  2007cites this paper
• CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.

  2007cites this paper
• New directions in the genomics of allogeneic hematopoietic stem cell transplantation.

  2007cites this paper
• Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

  2007cites this paper
• Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation – a case report

  2006cites this paper
• Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantation.

  2006cites this paper
• Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array.

  2006cites this paper
• T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction.

  2005cites this paper
• IL-4-producing CD8+ T cells may be an immunological hallmark of chronic GVHD

  2005cites this paper
• Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.

  2005cites this paper
• IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.

  2005cites this paper